Our advisory work starts from a position of respect
for our clients' organization, people,
products and science.
We have devoted our careers to the life
sciences industry and have the deepest respect
and admiration for the participants in it.
OUR TRACK RECORD
We are a very active advisor in the market.
Torreya Partners has successfully closed over
100 assignments since our founding in 2007.
We often take an operating perspective
to strategic and transaction work.
Sale to Merck
Up to $605 million
Asia, Africa, MidEast, Latin America
Sale of 22 generic products to ANI Pharmaceuticals
Sale to Mission Pharmacal
August 19-21, 2015
August 29 - September 2, 2015
September 2-3, 2015
Goldman Sachs Medtech and Healthcare Conference
July 28, 2015
Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics
July 13, 2015
ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million
June 9, 2014
Mission Pharmacal Acquires ProSolus Pharmaceuticals